Nicholas Lydon

Nicholas Lydon has an estimated net worth of $30.9 Million. This is based on reported shares across multiple companies, which include ANAPTYSBIO INC, and Blueprint Medicines Corp.

2017 was Nicholas Lydon's most active year for acquiring shares with 4 total transactions. Nicholas Lydon's most active month to acquire stocks was the month of May. 2018 was Nicholas Lydon's most active year for disposing of shares, totalling 12 transactions. Nicholas Lydon's most active month to dispose stocks was the month of May. 2017 saw Nicholas Lydon paying a total of $249,990.00 for 246,200 shares, this is the most they've acquired in one year. In 2017 Nicholas Lydon cashed out on 273,625 shares for a total of $2,803,724.00, their largest year based on trade value.